List of works by Matthew R Sydes

'Thursday's child has far to go'-interpreting subgroups and the STAMPEDE trial.

scientific article published in October 2017

A Systematic Review and Recommendation for Reporting of Surrogate Endpoint Evaluation Using Meta-analyses

scientific article published on 06 February 2019

A cohort examination to establish reporting of the remit and function of Trial Steering Committees in randomised controlled trials.

scientific article published on 8 December 2017

A comparison of dose–volume constraints derived using peak and longitudinal definitions of late rectal toxicity

article

A double-blind, placebo-controlled, randomized trial of oral sodium clodronate for metastatic prostate cancer (MRC PR05 Trial).

scientific article published in September 2003

A framework for the design and analysis of phase III randomised trials in uncommon diseases.

scientific article

A genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicity

scientific article published on 28 April 2014

A novel method to address the association between received dose intensity and survival outcome: benefits of approaching treatment intensification at a more individualised level in a trial of the European Osteosarcoma Intergroup

scientific article published on 16 March 2019

A study protocol of qualitative data sharing practices in clinical trials in the UK and Ireland: towards the production of good practice guidance

scientific article published in 2021

A third trial oversight committee: Functions, benefits and issues

scientific article published on 30 October 2019

A three-stage genome-wide association study identifies a susceptibility locus for late radiotherapy toxicity at 2q24.1.

scientific article published on 29 June 2014

Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy.

scientific article published on 3 June 2017

Abiraterone in "High-" and "Low-risk" Metastatic Hormone-sensitive Prostate Cancer

scientific article published on 23 August 2019

Access to routinely collected health data for clinical trials - review of successful data requests to UK registries

scientific article published on 12 May 2020

Accuracy and reproducibility of conformal radiotherapy using data from a randomised controlled trial of conformal radiotherapy in prostate cancer (MRC RT01, ISRCTN47772397)

scientific article

Adaptive platform trials using multi-arm, multi-stage protocols: getting fast answers in pandemic settings

scientific article published on 09 September 2020

Adding Celecoxib With or Without Zoledronic Acid for Hormone-Naïve Prostate Cancer: Long-Term Survival Results From an Adaptive, Multiarm, Multistage, Platform, Randomized Controlled Trial.

scientific article published on 13 March 2017

Adding abiraterone or docetaxel to long-term hormone therapy for prostate cancer: directly randomised data from the STAMPEDE multi-arm, multi-stage platform protocol.

scientific article published on 26 February 2018

Adding abiraterone to androgen deprivation therapy in men with metastatic hormone-sensitive prostate cancer: A systematic review and meta-analysis

scientific article

Adding new experimental arms to randomised clinical trials: Impact on error rates

scientific article published on 17 February 2020

Addition of docetaxel or bisphosphonates to standard of care in men with localised or metastatic, hormone-sensitive prostate cancer: a systematic review and meta-analyses of aggregate data

scientific article

Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial

scientific article published on 21 December 2015

Adjuvant Radiotherapy After Prostatectomy: Does Waiting for a Detectable Prostate-Specific Antigen Level Make Sense?: In Regard to King CR (Int J Radiat Oncol Biol Phys 2011;80:1–3)

article

Adjuvant Radiotherapy After Surgery for Prostate Cancer

scientific article published in The Journal of the American Medical Association

Adjuvant therapy with oral sodium clodronate in locally advanced and metastatic prostate cancer: long-term overall survival results from the MRC PR04 and PR05 randomised controlled trials

scientific article published on 10 August 2009

An ethnographic study of group decision making to understand and improve how trial steering committees contribute to trial conduct

scientific article published on 29 November 2013

An international evaluation of CODOX-M and CODOX-M alternating with IVAC in adult Burkitt's lymphoma: results of United Kingdom Lymphoma Group LY06 study

scientific article

Applying for ethical approval for research in the United Kingdom

scientific article published on 16 October 2009

Assessing correlations between the spatial distribution of the dose to the rectal wall and late rectal toxicity after prostate radiotherapy: an analysis of data from the MRC RT01 trial (ISRCTN 47772397).

scientific article

BA08: An open-label, single-arm, non-randomised, phase 2 trial of cisplatin, methotrexate and vinblastine (CMV) for pure squamous cell cancer of the urinary tract

scientific article published in PLoS ONE

Benefits and adverse events in younger versus older patients receiving neoadjuvant chemotherapy for osteosarcoma: findings from a meta-analysis

scientific article

Can we deliver randomized trials of focal therapy in prostate cancer?

scientific article published on 22 April 2014

Celecoxib plus hormone therapy versus hormone therapy alone for hormone-sensitive prostate cancer: first results from the STAMPEDE multiarm, multistage, randomised controlled trial

scientific article

Changing platforms without stopping the train: experiences of data management and data management systems when adapting platform protocols by adding and closing comparisons.

scientific article published on 29 May 2019

Clinical trial designs for rare diseases: studies developed and discussed by the International Rare Cancers Initiative

scientific article

Clinico-histologic parameters of osteosarcoma patients with late relapse

scientific article published on 19 January 2006

Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial

scientific article published on 2 November 2011

Combining Enzalutamide with Abiraterone, Prednisone, and Androgen Deprivation Therapy in the STAMPEDE Trial

scientific article published on 27 June 2014

Comments on 'A modest proposal for dropping poor arms in clinical trials' by Proschan and Dodd

scientific article

Common genetic variation associated with increased susceptibility to prostate cancer does not increase risk of radiotherapy toxicity

scientific article published on 12 April 2016

Comparison of ABVD and alternating or hybrid multidrug regimens for the treatment of advanced Hodgkin's lymphoma: results of the United Kingdom Lymphoma Group LY09 Trial (ISRCTN97144519).

scientific article published on 28 November 2005

Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial.

scientific article

Comparison of Outcomes in Studies of Advanced Hodgkin's Lymphoma

scientific article published on 01 July 2006

Consolidation radiotherapy in patients with advanced Hodgkin's lymphoma: survival data from the UKLG LY09 randomized controlled trial (ISRCTN97144519).

scientific article

Costs and staffing resource requirements for adaptive clinical trials: quantitative and qualitative results from the Costing Adaptive Trials project

scientific article published on 26 October 2021

Cross-sectional analysis of UK research studies in 2015: results from a scoping project with the UK Health Research Authority

article

Data sharing and the evolving role of statisticians

scientific article

Defining the Need for Local Therapy in Locally Advanced Prostate Cancer: An Appraisal of the MRC PR07 Study

scientific article published on 01 June 2005

Dose-volume constraints to reduce rectal side effects from prostate radiotherapy: evidence from MRC RT01 Trial ISRCTN 47772397.

scientific article published on 18 June 2009

EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatment

scientific article

Early Salvage Radiotherapy After Radical Prostatectomy

Emotion Detection in Suicide Notes using Maximum Entropy Classification

scientific article published on 30 January 2012

Enhancing public involvement in trial oversight committees through qualitative research with eight trials facing challenges.

scientific article published on 16 November 2015

Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: long-term results from the MRC RT01 randomised controlled trial

scientific article

Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial

scientific article published in June 2007

Estimating the Impact of Randomised Control Trial Results on Clinical Practice: Results from a Survey and Modelling Study of Androgen Deprivation Therapy plus Radiotherapy for Locally Advanced Prostate Cancer

scientific article published on August 2016

Evaluating the relationship between erectile dysfunction and dose received by the penile bulb: using data from a randomised controlled trial of conformal radiotherapy in prostate cancer (MRC RT01, ISRCTN47772397).

scientific article

Event-Free Survival, a Prostate-Specific Antigen-Based Composite End Point, Is Not a Surrogate for Overall Survival in Men With Localized Prostate Cancer Treated With Radiation

scientific article published on 18 June 2020

Exploring the role and function of trial steering committees: results of an expert panel meeting

scientific article

Exploring the role and functionality of trial steering committees.

scientific article published on 16 November 2015

Expression of Bcl-2, p53, and MDM2 in localized prostate cancer with respect to the outcome of radical radiotherapy dose escalation

scientific article published on 21 January 2010

Failure-Free Survival and Radiotherapy in Patients With Newly Diagnosed Nonmetastatic Prostate Cancer: Data From Patients in the Control Arm of the STAMPEDE Trial

scientific article

Final Report of the Intergroup Randomized Study of Combined Androgen-Deprivation Therapy Plus Radiotherapy Versus Androgen-Deprivation Therapy Alone in Locally Advanced Prostate Cancer

scientific article published on 17 February 2015

Flexible trial design in practice - stopping arms for lack-of-benefit and adding research arms mid-trial in STAMPEDE: a multi-arm multi-stage randomized controlled trial

scientific article

Flexible trial design in practice – dropping and adding arms in STAMPEDE: a multi-arm multi-stage randomised controlled trial

scientific article

Good practice principles for sharing individual participant data from publicly funded clinical trials.

scientific article

High-dose therapy improves progression-free survival and survival in relapsed follicular non-Hodgkin's lymphoma: results from the randomized European CUP trial

scientific article published on 29 September 2003

How do you design randomised trials for smaller populations? A framework.

scientific article

How should individual participant data (IPD) from publicly funded clinical trials be shared?

scientific article

Impact of Radiotherapy When Added to Androgen-Deprivation Therapy for Locally Advanced Prostate Cancer: Long-Term Quality-of-Life Outcomes From the NCIC CTG PR3/MRC PR07 Randomized Trial

scientific article published on 26 May 2015

Impact of retrospective data verification to prepare the ICON6 trial for use in a marketing authorization application

scientific article published on 26 July 2019

Implementing monitoring triggers and matching of triggered and control sites in the TEMPER study: a description and evaluation of a triggered monitoring management system

scientific article published on 17 April 2019

Implementing the UK Medical Research Council (MRC) RT01 trial (ISRCTN 47772397): methods and practicalities of a randomised controlled trial of conformal radiotherapy in men with localised prostate cancer.

scientific article published in August 2004

Improvement in histologic response but not survival in osteosarcoma patients treated with intensified chemotherapy: a randomized phase III trial of the European Osteosarcoma Intergroup.

scientific article

Incorporating Biomarker Stratification into STAMPEDE: an Adaptive Multi-arm, Multi-stage Trial Platform

scientific article published on 24 October 2017

Increased Dose to Organs in Urinary Tract Associates With Measures of Genitourinary Toxicity in Pooled Voxel-Based Analysis of 3 Randomized Phase III Trials

scientific article published on 22 July 2020

Independent validation of genes and polymorphisms reported to be associated with radiation toxicity: a prospective analysis study

scientific article

Individual patient data meta-analysis shows a significant association between the ATM rs1801516 SNP and toxicity after radiotherapy in 5456 breast and prostate cancer patients

scientific article

Initial dose intensity has limited impact on the outcome of ABVD chemotherapy for advanced Hodgkin lymphoma (HL): data from UKLG LY09 (ISRCTN97144519).

scientific article

Interim monitoring of efficacy data is important and appropriate

scientific article

International collaboration is feasible in trials for rare conditions: the EURAMOS experience

scientific article published on January 2009

Intrinsic markers of tumour hypoxia and angiogenesis in localised prostate cancer and outcome of radical treatment: a retrospective analysis of two randomised radiotherapy trials and one surgical cohort study

scientific article published on 17 March 2008

Is duplex surveillance of value after leg vein bypass grafting? Principal results of the Vein Graft Surveillance Randomised Trial (VGST).

scientific article published in September 2005

Issues in applying multi-arm multi-stage methodology to a clinical trial in prostate cancer: the MRC STAMPEDE trial

scientific article published on 11 June 2009

Late gastrointestinal toxicity after dose-escalated conformal radiotherapy for early prostate cancer: results from the UK Medical Research Council RT01 trial (ISRCTN47772397).

scientific article published on 14 October 2009

Making randomised trials more efficient: report of the first meeting to discuss the Trial Forge platform

scientific article published on 5 June 2015

Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019

scientific article published on 27 January 2020

Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017.

scientific article

Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer

scientific article published on 20 July 2016

Metastasis-Free Survival Is a Strong Surrogate of Overall Survival in Localized Prostate Cancer

scientific article published on 10 August 2017

Method to measure the mismatch between target and achieved received dose intensity of chemotherapy in cancer trials: a retrospective analysis of the MRC BO06 trial in osteosarcoma

scientific article published on 30 May 2019

Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good R

scientific article

Mind the gap? The platform trial as a working environment.

scientific article published on 29 May 2019

Monitoring in practice - How are UK academic clinical trials monitored? A survey

scientific article published on 09 January 2020

More multiarm randomised trials of superiority are needed

scientific article published on July 2014

No socioeconomic inequalities in colorectal cancer survival within a randomised clinical trial.

scientific article published on 28 October 2008

No socioeconomic inequalities in ovarian cancer survival within two randomised clinical trials.

scientific article

Older Age, Early Symptoms and Physical Function are Associated with the Severity of Late Symptom Clusters for Men Undergoing Radiotherapy for Prostate Cancer

scientific article published on 16 February 2018

Oral Sodium Clodronate for Nonmetastatic Prostate Cancer--Results of a Randomized Double-Blind Placebo-Controlled Trial: Medical Research Council PR04 (ISRCTN61384873)

scientific article published on 01 May 2007

Outcomes and endpoints in cancer trials: bridging the divide

scientific article

Overlap between adverse events (AEs) and serious adverse events (SAEs): a case study of a phase III cancer clinical trial

scientific article published on 17 September 2020

PROSTATE RADIOTHERAPY AFTER RADICAL PROSTATECTOMY: SOONER OR LATER?

Parameters for the Lyman Kutcher Burman (LKB) model of Normal Tissue Complication Probability (NTCP) for specific rectal complications observed in clinical practise

article

Parenteral oestrogen in the treatment of prostate cancer: a systematic review

scientific article

Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group

scientific article published on March 1999

Perioperative beta-blockade (POBBLE) for patients undergoing infrarenal vascular surgery: results of a randomized double-blind controlled trial

scientific article published in April 2005

Postoperative radiotherapy after radical prostatectomy: let's work together to tackle the known unknowns

scientific article published on 27 September 2013

Potential pitfalls in the design and reporting of clinical trials

scientific article

Practical methods for incorporating summary time-to-event data into meta-analysis

scientific article (publication date: 7 June 2007)

Presence of chemotherapy-induced toxicity predicts improved survival in patients with localised extremity osteosarcoma treated with doxorubicin and cisplatin: a report from the European Osteosarcoma Intergroup.

scientific article

Proposals on Kaplan-Meier plots in medical research and a survey of stakeholder views: KMunicate

scientific article published on 30 September 2019

Prospective data linkage to facilitate COVID-19 trials - A call to action

scientific article published on 11 August 2020

Prostate Radiotherapy for Metastatic Hormone-sensitive Prostate Cancer: A STOPCAP Systematic Review and Meta-analysis

scientific article published on 28 February 2019

Prostate radiotherapy for men with metastatic disease: a new comparison in the STAMPEDE trial

scientific article published on 13 March 2013

Prostate radiotherapy for men with metastatic disease: a new comparison in the Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug Efficacy (STAMPEDE) trial

scientific article

Quality of Life of Patients With Osteosarcoma in the European American Osteosarcoma Study-1 (EURAMOS-1): Development and Implementation of a Questionnaire Substudy

scientific article published on 26 September 2019

RADICALS (Radiotherapy and Androgen Deprivation in Combination after Local Surgery)

scientific article published on 07 February 2007

Radiogenomics Consortium Genome-Wide Association Study Meta-analysis of Late Toxicity after Prostate Cancer Radiotherapy

article

Radiotherapy and androgen deprivation in combination after local surgery (RADICALS): A new Medical Research Council/National Cancer Institute of Canada phase III trial of adjuvant treatment after radical prostatectomy

article

Randomized trials in early prostate cancer. II: hormone therapy and radiotherapy for locally advanced disease: a question is still unanswered. MRC PR07 Trial Management Group

article

Re: Andrew J. Stephenson, Michel Bolla, Alberto Briganti, et al. Postoperative Radiation Therapy for Pathologically Advanced Prostate Cancer After Radical Prostatectomy. Eur Urol 2012;61:443–51

scientific article published on 11 September 2012

Re: Christopher J.D. Wallis, Zachary Klaassen, Bimal Bhindi, et al. Comparison of Abiraterone Acetate and Docetaxel with Androgen Deprivation Therapy in High-risk and Metastatic Hormone-naïve Prostate Cancer: A Systematic Review and Network Meta-ana

scientific article

Re: Ofer Yossepowitch, Anders Bjartell, James A. Eastham, et al. Positive surgical margins in radical prostatectomy: outlining the problem and its long-term consequences. Eur Urol 2009;55:87-99.

scientific article published on 13 March 2009

Re: Sanoj Punnen, Matthew R. Cooperberg, Anthony V. D'Amico, et al. Management of biochemical recurrence after primary treatment of prostate cancer: a systematic review of the literature. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2013.05

Re: Ute Ganswindt, Arnulf Stenzl, Michael Bamberg and Claus Belka. Adjuvant Radiotherapy for Patients with Locally Advanced Prostate Cancer—A New Standard? Eur Urol 2008;54:528–42

Reflections on attempted Anglo-Japanese collaboration on STAMPEDE: A randomized controlled trial for men with prostate cancer

article

Reply to Che-Kai Tsao, Matthew D. Galsky, and William K. Oh's Platinum Opinion. Docetaxel for Metastatic Hormone-Sensitive Prostate Cancer: Urgent Need To Minimize The Risk Of Neutropenic Fever. Eur Urol 2016;70:707-708

scientific article published on 06 October 2016

Reported use of data monitoring committees in the main published reports of randomized controlled trials: a cross-sectional study

scientific article

Reporting remit and function of trial steering committees in randomised controlled trials: review of published literature.

scientific article published on 16 November 2015

Repurposing Metformin as Therapy for Prostate Cancer within the STAMPEDE Trial Platform

scientific article published on 19 July 2016

Resolving the Optimal Timing of Radiotherapy After Radical Prostatectomy: The Need for Further Research

Response to ‘High Risk of Neutropenia for Hormone-naive Prostate Cancer Patients Receiving STAMPEDE-style Upfront Docetaxel Chemotherapy in Usual Clinical Practice’, by Tanguay et al

scientific article published on 29 July 2016

Response to: Practical methods for incorporating summary time-to-event data into meta-analysis

scientific article published on 19 November 2013

Revisiting Intermittent Therapy in Metastatic Prostate Cancer: Can Less Be More in the "New World Order"?

scientific article published on 23 February 2019

STAMPEDE trial and patients with non-metastatic prostate cancer - Authors' reply

scientific article published on 01 July 2016

STAMPEDE: Systemic Therapy for Advancing or Metastatic Prostate Cancer--a multi-arm multi-stage randomised controlled trial

scientific article published on 29 August 2008

Salvage Treatment After Radical Prostatectomy

scientific article published on 02 August 2017

Secondary malignant neoplasms, progression-free survival and overall survival in patients treated for Hodgkin lymphoma: A systematic review and meta-analysis of randomized clinical trials.

scientific article published on 14 September 2017

Sharing data from clinical trials: the rationale for a controlled access approach

scientific article

Socio-economic inequalities in testicular cancer survival within two clinical studies.

scientific article published on 3 September 2011

Speeding up the evaluation of new agents in cancer

scientific article published on 26 August 2008

Survival after recurrent osteosarcoma: data from 3 European Osteosarcoma Intergroup (EOI) randomized controlled trials

scientific article

Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort

scientific article published on 25 January 2019

Survival from high-grade localised extremity osteosarcoma: combined results and prognostic factors from three European Osteosarcoma Intergroup randomised controlled trials.

scientific article

Survival with Newly Diagnosed Metastatic Prostate Cancer in the "Docetaxel Era": Data from 917 Patients in the Control Arm of the STAMPEDE Trial (MRC PR08, CRUK/06/019).

scientific article

Symptom clusters for revising scale membership in the analysis of prostate cancer patient reported outcome measures: a secondary data analysis of the Medical Research Council RT01 trial (ISCRTN47772397).

scientific article published on 28 March 2017

Systematic Review and Individual Patient Data Meta-analysis of Randomized Trials Comparing a Single Immediate Instillation of Chemotherapy After Transurethral Resection with Transurethral Resection Alone in Patients with Stage pTa-pT1 Urothelial Car

scientific article

Systematic qualitative review of the literature on data monitoring committees for randomized controlled trials

scientific article

Systemic therapy for advancing or metastatic prostate cancer (STAMPEDE): a multi-arm, multistage randomized controlled trial

scientific article

Systemic therapy for vulval Erosive Lichen Planus (the 'hELP' trial): study protocol for a randomised controlled trial

scientific article published on 4 January 2016

Testing many treatments within a single protocol over 10 years at MRC Clinical Trials Unit at UCL: Multi-arm, multi-stage platform, umbrella and basket protocols.

scientific article published in August 2017

The CUP trial: a randomized study analyzing the efficacy of high dose therapy and purging in low-grade non-Hodgkin's lymphoma (NHL)

scientific article published on 01 January 2000

The dose-response of the anal sphincter region--an analysis of data from the MRC RT01 trial

scientific article

The early toxicity of escalated versus standard dose conformal radiotherapy with neo-adjuvant androgen suppression for patients with localised prostate cancer: Results from the MRC RT01 trial (ISRCTN47772397)

article

The impact of clinical factors on the development of late radiation toxicity: results from the Medical Research Council RT01 trial (ISRCTN47772397).

scientific article

The need for a cultural shift from two-arm to multi-arm RCTS.

scientific article published on 29 November 2013

The quality of life of men with locally advanced prostate cancer during neoadjuvant hormone therapy: data from the Medical Research Council RT01 trial (ISRCTN 47772397).

scientific article

The value of evidence synthesis in randomised controlled trial (RCT) design, conduct and analysis: MRC clinical trials unit (CTU) at UCL experience.

scientific article published on 16 November 2015

This is a platform alteration: a trial management perspective on the operational aspects of adaptive and platform and umbrella protocols.

scientific article

Transdermal Oestradiol as a method of androgen suppression for Prostate Cancer within the STAMPEDE Trial Platform

scientific article published in February 2018

Trial Steering Committees in randomised controlled trials: A survey of registered clinical trials units to establish current practice and experiences

scientific article

Trial steering committees for randomised controlled trials: updating and redeveloping guidance and terms of reference informed by current practice and experience.

scientific article published on 29 November 2013

Triggered or routine site monitoring visits for randomised controlled trials: results of TEMPER, a prospective, matched-pair study

UK publicly funded Clinical Trials Units supported a controlled access approach to share individual participant data but highlighted concerns

scientific article

Use of routinely collected health data in randomised clinical trials: comparison of trial-specific death data in the BOSS trial with NHS Digital data

scientific article published on 26 September 2021

Using implicit information to identify smoking status in smoke-blind medical discharge summaries

scientific article published on 18 October 2007

What is the optimal systemic treatment of men with metastatic, hormone-naive prostate cancer? A STOPCAP systematic review and network meta-analysis.

scientific article

Will chemotherapy change the management of prostate cancer?

scientific article published on 22 December 2015

Workshop report on the 2nd Joint ENCCA/EuroSARC European bone sarcoma network meeting: integration of clinical trials with tumour biology

scientific article published in May 2014